CYTOKINES AND SEPSIS - TIME FOR REAPPRAISAL

被引:3
作者
YENTIS, SM
机构
关键词
D O I
10.1093/bja/74.2.119
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:119 / 120
页数:2
相关论文
共 17 条
[1]   SEPSIS THERAPY TRIALS - CONTINUED DISAPPOINTMENT OR REASON FOR HOPE [J].
ABRAHAM, E ;
RAFFIN, TA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1876-1878
[2]   TREATMENT WITH RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA PROTECTS RATS AGAINST THE LETHALITY, HYPOTENSION, AND HYPOTHERMIA OF GRAM-NEGATIVE SEPSIS [J].
ALEXANDER, HR ;
SHEPPARD, BC ;
JENSEN, JC ;
LANGSTEIN, HN ;
BURESH, CM ;
VENZON, D ;
WALKER, EC ;
FRAKER, DL ;
STOVROFF, MC ;
NORTON, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :34-39
[3]   PROJECTED IMPACT OF MONOCLONAL ANTIENDOTOXIN ANTIBODY THERAPY [J].
BATES, DW ;
LEE, TH .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (11) :1241-1249
[4]   IMPLICATIONS OF ENDOTOXIN CONTAMINATION IN THE EVALUATION OF ANTIBODIES TO LIPOPOLYSACCHARIDES IN A MURINE MODEL OF GRAM-NEGATIVE SEPSIS [J].
CHONG, KT ;
HUSTON, M .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (05) :713-719
[5]   ANTICYTOKINE STRATEGIES IN THE TREATMENT OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME [J].
DINARELLO, CA ;
GELFAND, JA ;
WOLFF, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (14) :1829-1835
[6]  
DINARELLO CA, 1994, ANN INTERN MED, V119, P853
[7]   MEDIATORS OF SEPTIC SHOCK - NEW APPROACHES FOR INTERRUPTING THE ENDOGENOUS INFLAMMATORY CASCADE [J].
GIROIR, BP .
CRITICAL CARE MEDICINE, 1993, 21 (05) :780-789
[8]  
HOFFMAN WD, 1993, ANESTH ANALG, V77, P613
[9]   INTERLEUKIN-1 PRETREATMENT PROTECTS AGAINST ENDOTOXIN-INDUCED HYPOTENSION IN RABBITS - ASSOCIATION WITH DECREASED TUMOR-NECROSIS-FACTOR LEVELS [J].
KAPLAN, E ;
DINARELLO, CA ;
WAKABAYASHI, G ;
BURKE, JF ;
CONNOLLY, RS ;
GELFAND, JA .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :244-247
[10]   INTRODUCTION OF NEW TECHNOLOGY INTO CRITICAL CARE PRACTICE - A HISTORY OF HA-1A HUMAN MONOCLONAL-ANTIBODY AGAINST ENDOTOXIN [J].
LUCE, JM .
CRITICAL CARE MEDICINE, 1993, 21 (08) :1233-1241